ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesD19.0

D19.0

Billable

Benign neoplasm of mesothelial tissue of pleura

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 D19.0 is a billable code used to indicate a diagnosis of benign neoplasm of mesothelial tissue of pleura.

Key Diagnostic Point:

Benign neoplasms of mesothelial tissue of the pleura are non-cancerous growths that arise from the mesothelial cells lining the pleura, which is the membrane surrounding the lungs. These neoplasms can present as solitary tumors or as part of a more extensive pleural disease. Clinically, they may be asymptomatic or cause symptoms such as chest pain, dyspnea, or pleuritic pain, depending on their size and location. Diagnosis typically involves imaging studies such as chest X-rays or CT scans, and may require biopsy for definitive diagnosis. While benign, these neoplasms necessitate careful monitoring due to their potential for local invasion or, in rare cases, transformation into malignant forms. Regular follow-up with imaging is often recommended to assess for any changes in size or characteristics. The management of benign pleural neoplasms may include surgical resection if symptomatic or if there is concern for malignancy. Understanding the benign nature of these tumors is crucial for appropriate coding and management.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Differentiation from malignant pleural neoplasms
  • Need for precise documentation of tumor characteristics
  • Potential for local invasion requiring careful monitoring
  • Variability in clinical presentation and symptoms

Audit Risk Factors

  • Inadequate documentation of tumor characteristics
  • Failure to document follow-up imaging results
  • Misclassification as malignant neoplasm
  • Lack of clarity on symptoms related to the neoplasm

Specialty Focus

Medical Specialties

Pulmonology

Documentation Requirements

Detailed imaging reports, biopsy results, and clinical notes on symptoms.

Common Clinical Scenarios

Patients presenting with pleuritic chest pain or incidental findings on imaging.

Billing Considerations

Ensure clear documentation of the benign nature and any follow-up plans.

Oncology

Documentation Requirements

Pathology reports confirming benign status and any treatment plans.

Common Clinical Scenarios

Patients with a history of pleural neoplasms undergoing surveillance.

Billing Considerations

Document any changes in tumor characteristics during follow-up.

Coding Guidelines

Inclusion Criteria

Use D19.0 When
  • According to ICD
  • 10 guidelines, D19
  • 0 should be used when a benign neoplasm of mesothelial tissue of the pleura is confirmed
  • It is essential to document the benign nature and any relevant imaging or biopsy results

Exclusion Criteria

Do NOT use D19.0 When
  • Exclusions include malignant neoplasms of the pleura

Related ICD-10 Codes

Related CPT Codes

32405CPT Code

Thoracotomy, with excision of pleural tumor

Clinical Scenario

Used when a patient with a benign pleural neoplasm requires surgical intervention.

Documentation Requirements

Operative report detailing the procedure and findings.

Specialty Considerations

Ensure that the diagnosis of benign neoplasm is clearly documented in the surgical notes.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of benign neoplasms, improving the accuracy of patient records and facilitating better tracking of these conditions. D19.0 provides a clear distinction from malignant neoplasms, which is critical for treatment and management.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of benign neoplasms, improving the accuracy of patient records and facilitating better tracking of these conditions. D19.0 provides a clear distinction from malignant neoplasms, which is critical for treatment and management.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of benign neoplasms, improving the accuracy of patient records and facilitating better tracking of these conditions. D19.0 provides a clear distinction from malignant neoplasms, which is critical for treatment and management.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What is the significance of coding D19.0 accurately?

Accurate coding of D19.0 is crucial for proper patient management, ensuring appropriate follow-up and surveillance, and avoiding misclassification as malignant, which could lead to unnecessary treatments.